Principia Biopharma Inc. Patent Application Trends in 2024
Jump to navigation
Jump to search
Contents
Principia Biopharma Inc. Patent Filing Activity
Principia Biopharma Inc. patent applications in 2024
Top 10 Technology Areas
- A61K31/519 (No explanation available)
- Count: 4 patents
- Example: [[20240207275. Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile simplified abstract (Principia Biopharma Inc.)]]
- C07D487/04 (No explanation available)
- C07B2200/13 (No explanation available)
- Count: 2 patents
- Example: [[20240182484. Crystalline Forms 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1- YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2- Enenitrile simplified abstract (Principia Biopharma Inc.)]]
- A61K31/5377 (No explanation available)
- A61K45/06 (No explanation available)
- C07D519/00 (No explanation available)
- C07D487/14 (No explanation available)
- Count: 1 patents
- Example: [[20240182484. Crystalline Forms 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1- YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2- Enenitrile simplified abstract (Principia Biopharma Inc.)]]
- C07F5/025 (No explanation available)
- Count: 1 patents
- Example: 20240199655. Immunoproteasome Inhibitors simplified abstract (Principia Biopharma Inc.)
- A61K9/2018 (No explanation available)
- Count: 1 patents
- Example: [[20240207275. Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile simplified abstract (Principia Biopharma Inc.)]]
- A61K9/2846 (No explanation available)
- Count: 1 patents
- Example: [[20240207275. Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile simplified abstract (Principia Biopharma Inc.)]]
Emerging Technology Areas
- C07D471/04 (No explanation available)
- C07D405/12 (No explanation available)
- C07D403/12 (No explanation available)
- C07D401/14 (No explanation available)
- A61K31/506 (No explanation available)
- A61K31/495 (No explanation available)
- A61K9/0053 (No explanation available)
- A61P7/04 (No explanation available)
- A61P7/02 (No explanation available)
- A61K9/5073 (No explanation available)
- Count: 1 patents
- Example: [[20240207275. Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile simplified abstract (Principia Biopharma Inc.)]]
Top Inventors
- Pasit Phiasivongsa of Hillsborough CA (US) (2 patents)
- Kolbot By of San Ramon CA (US) (2 patents)
- Mohammad R. Masjedizadeh of San Jose CA (US) (2 patents)
- Erik Verner of Belmont CA (US) (2 patents)
- Jean Baum of San Bruno CA (US) (1 patent)
- Yan Lou of Pleasanton CA (US) (1 patent)
- Timothy Duncan Owens of Redwood City CA (US) (1 patent)
- Kenneth Albert Brameld of Hillsborough CA (US) (1 patent)
- David Michael Goldstein of Redwood City CA (US) (1 patent)
- Abu J. Ferdous of Belmont CA (US) (1 patent)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
Categories:
- Principia Biopharma Inc.
- Companies
- CPC C07D487/14
- CPC C07B2200/13
- CPC C07F5/025
- CPC A61K31/519
- CPC A61K9/2018
- CPC A61K9/2846
- CPC A61K9/2866
- CPC A61K9/2886
- CPC A61K9/5026
- CPC A61K9/5047
- CPC A61K9/5073
- CPC A61P7/02
- CPC A61P7/04
- CPC C07D487/04
- CPC A61K9/0053
- CPC A61K31/495
- CPC A61K31/506
- CPC A61K31/5377
- CPC A61K45/06
- CPC C07D401/14
- CPC C07D403/12
- CPC C07D405/12
- CPC C07D519/00
- CPC C07D471/04
- Patent Trends by Company in 2024
